Valve confirmed today that its engineers are actively collaborating with NVIDIA on driver support for SteamOS, the company's Linux-based gaming operating system — while simultaneously opening the ...

Dr Oliver Sartor of the Transformational Prostate Cancer Research Center in New Orleans reviews key prostate cancer studies from the 2026 American Society of Clinical Oncology Annual Meeting. He ...

‘If we say no, then they never talk to us again.’ ‘If we say no, then they never talk to us again.’ is a senior reporter covering technology, gaming, and more. He joined The Verge in 2019 after nearly ...

The Steam Machine is almost here. Valve chose possibly the worst time to announce new PC gaming hardware in late 2025, just as the AI boom sent storage and RAM prices through the roof. The upheaval ...

Valve's new Steam Machines will arrive this summer and start at $1,049, the company announced Monday. Valve, which released its new Steam Controller in May and has a new VR headset coming called Steam ...

Ms. Harrington and Ms. Emanuel are labor economists and authors of the forthcoming book “In Person: How Working Together Fuels Creativity, Productivity, and Growth.” Most Americans say they love ...

Each year, the global oncology community flocks to Chicago to convene at the American Society of Clinical Oncology’s annual meeting for a weekend of buzzy data drops, practice-changing posters and ...

ASCO didn’t always look like a massive cityscape of pharma booths with a strong advertising presence. Historically, the heavy focus was on medical affairs, given the conference is mainly attended by ...

RASolute 302 showed daraxonrasib reduced mortality risk by 60% versus chemotherapy in previously treated metastatic PDAC, with median OS 13.2 versus 6.7 months. OPTIMA found Prosigna-defined low-risk ...

ASCO 2026 clinicians highlighted unmet needs from navigating complex treatment decisions and overcoming translation gaps, to optimizing regimens. At the 2026 annual meeting of the American Society of ...

While Revolution Medicines dominated this year’s American Society of Clinical Oncology annual meeting by conquering the “undruggable” RAS pathway, another up-and-coming biotech hopes to do the same ...